During NAFLD progression, the inflammatory mediators IL-6, IL-8, IL-1β and TNF-α are regulated by a critical nuclear transcription factor, NF-κB [19]. Here, CXCL8 is linked to metabolic dysfunction-associated steatotic liver disease.